InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by FALBERG KATHRYN E, Director. Insider active across 4 companies, notably Trade Desk, Inc.. Cumulatively, 10 disclosures have been logged. Total volume traded: €15.3m. The latest transaction was disclosed on 14 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
04,100 shares0
Common Stock
SEC:0001209191-22-037408:0·
04,178 shares0
Class A Common Stock
SEC:0001209191-22-032865:0·
€8m80,563 shares@ €95.02640.077% mcap100.0% of flow
Class A Common Stock
SEC:0001209191-21-066629·
€8m80,563 shares@ €95.02640.077% mcap100.0% of flow
Class A Common Stock
SEC:0001209191-21-066629:0·
016,403 shares0
Common Stock
SEC:0001595585-21-000077:0·
016,403 shares0
Common Stock
SEC:0001595585-21-000077·
03,000 shares0
Common Stock
SEC:0001209191-21-038616·
03,000 shares0
Common Stock
SEC:0001209191-21-038616:0·
0390 shares0
Class A Common Stock
SEC:0001209191-21-036982·
0390 shares0
Class A Common Stock
SEC:0001209191-21-036982:0·
10 of 10 declarations
About FALBERG KATHRYN E
Kathryn E. Falberg is a Director at Trade Desk, Inc., Arcus Biosciences, Inc., and Tricida, Inc. She plays a key role in overseeing the activities of these companies and guiding their strategy. Kathryn leverages her expertise to contribute to strategic decision-making within the boards.
